Insights
Insights From Our Experts
Articles
Staying Ahead of the Curve in Pharmacovigilance: Emerging Regulations and Their Implications in Saudi Arabia
Our Pharmacovigilance experts actively track evolving global regulations—so you don’t have to. To help simplify pharmacovigilance, we stay ahead of new regulations, assess their impact on current practices, and recommend actions that empower professionals to update…
One Team, One Voice: The Impact of Centralized Medical Content Development
Featured Study – One Team, One Voice The Impact of Centralized Medical Content Development Presented at MAPS 2025. Objective: A survey was conducted to better understand Medical Affairs (MA) professionals’ strategies for medical content development, utilizing…
Maximizing Medical Affairs and MSL Impact: How Choosing a Strategic Launch Partner Propels Success
Medical Science Liaisons (MSLs) serve as the bridge between pharmaceutical companies, healthcare professionals, and the scientific community. Their impact reverberates across the entire healthcare ecosystem as they are essential for fostering scientific dialogue, driving evidence-based medicine,…
Uncovering the Drivers of Satisfaction for Patient Services
As the needs of patients and healthcare providers evolve, it is essential to continuously adapt support services to meet these changing demands. Dive into our latest article to discover strategies for improving patient and provider experiences…
The Evidence Gap No One Talks About
In the excitement of global drug launches, a critical issue often overlooked is the lack of local clinical evidence in many Asia-Pacific countries. This gap forces healthcare providers to rely on Western data, which may not…
Unlocking Pharma Success: Mike Ryan’s Pre-Conference Talk at Reuters Pharma 2025
Mike Ryan, General Manager, Europe, at EVERSANA, connected in a conversation with PharmaShots before Reuters Pharma 2025 in Barcelona, which ran 9-11 April 2025. Mike’s discussion focused on the history of EVERSANA and how the company…
Unlock the Power of Indirect Treatment Comparisons (ITC) with Industry Experts
Are you gearing up for product launches and health technology assessment (HTA) submissions? Look no further! EVERSANA is proud to announce an exclusive course at the ISPOR Education Center, led by renowned experts Chris Cameron from…
CASE STUDY: Transforming Clinical Trials with EVERSANA
Modernizing Clinical Trials to Accelerate Access Clinical trials are essential for bringing life-changing therapies to market, yet traditional models often present significant barriers for both participants and trial sites. A leading pharmaceutical manufacturer partnered with EVERSANA…
Beyond Clinical Trials: Real-World Evidence Illuminates the Value of First-Line CDK4/6i in Metastatic Breast Cancer
While randomized controlled trials (RCTs) have been instrumental in establishing new standards of care, a comprehensive understanding of treatment effectiveness requires insights from real-world evidence (RWE). This is particularly true in the evolving landscape of hormone…
Case Study: Increasing Product Adoption Rate through EVERSANA’s Digital Hub Portal
Problem: Our client launched a new product in the U.S. market, but initial adoption rates were disappointingly low. Physicians, who were eager to incorporate this innovative product into their practice, hesitated to prescribe from the complexity…